Actively hiring
Biologics & Biosimilars
Health Care
Oncology Therapeutics
View 1 job
Claim pageClaim
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Latest round
Venture round
Sep 2025 · 12 mo ago
Hiring now
2
open roles
The money's age
Due for its next round
12 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
Last sign of life
4 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 26, 2025
Raised a round Venture round
Oct 14, 2024
Raised a round Venture round
Mar 27, 2024
Raised a round Venture round
Dec 16, 2022
Raised a round Venture round
Mar 5, 2022
Raised a round Venture round
Aug 19, 2021
Raised a round Venture round
May 20, 2021
Raised a round Venture round
Dec 26, 2020
Raised a round Venture round
Apr 5, 2020
Raised a round Venture round
Apr 5, 2019
Raised a round Venture round
Jul 31, 2018
Raised a round Venture round
Apr 5, 2018
Raised a round Venture round
Oct 24, 2017
Raised a round Venture round
May 23, 2017
Raised a round Venture round
Sep 27, 2016
Raised a round Venture round
May 6, 2015
Raised a round Venture round
Nov 14, 2014
Raised a round Venture round
Apr 18, 2013
Raised a round Venture round
Oct 13, 2011
Raised a round Venture round
Aug 20, 2010
Raised a round Venture round
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | COMPANY REGISTRATION Oxford BioTherapeutics Limited | its site |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Novel ADC Payloads for Cancer Hexagon Bio is developing novel payload mechanisms for antibody-drug conjugates (ADCs) to overcome resistance…

Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.

LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the…

THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…

We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.

Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
Overview
At Oxford BioTherapeutics, we are dedicated to pioneering the next generation of oncology treatments through targeted therapies, including Antibody-Drug Conjugates (ADC), Immuno-oncology, T-Cell Engagers (TCE), and radiopharmaceuticals.
Tech stack
Technologies named in job postings at Oxford BioTherapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
9
Postings analysed
1
Stack modernity
78/100
Languages
JavaScript
Python
TypeScript
C#
Frameworks & libraries
React.js
Cloud & platforms
.NET
AWS
Azure
GCP
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
10/20/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Backend
50% ▼
Science & Research
50% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Jose
San Jose
United States
HQ
1 open roles 100% engineering
hires for Science & Research
Jobs
In office • Full-Time • Bachelor's Degree
Python
JavaScript
TypeScript
C#
.NET
Frontend
React.js
DevOps
GCP
Azure
AWS
Management
Jira
Agile
Apply
Financials
Latest round
Venture - Series Unknown
Funding rounds
20
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Venture - Series Unknown | 2016 | — | Details |
| Venture - Series Unknown | 2015 | — | Details |
| Venture - Series Unknown | 2014 | — | Details |
| Venture - Series Unknown | 2013 | — | Details |
| Venture - Series Unknown | 2011 | — | Details |
| Venture - Series Unknown | 2010 | — | Details |






